Z. Huo et al. / Tetrahedron Letters 49 (2008) 5531–5533
5533
2. (a) Dzierszinski, F.; Coppin, A.; Mortuaire, M.; Dewally, E.; Slomianny, C.;
Ameisen, J.-C.; Debels, F.; Tomavo, S. Antimicrob. Agent. Chemother. 2002, 46,
3197; (b) Kletsas, D.; Li, W.; Han, Z.; Papadopoulos, V. Biochem. Pharmacol.
2004, 67, 1927; (c) Mach, U. R.; Hackling, A. E.; Perachon, S.; Ferry, S.;
Wermuth, C. G.; Schwartz, J.-C.; Sokoloff, P.; Stark, H. ChemBioChem 2004, 5,
508; (d) Muscarella, D. E.; O’Brian, K. A.; Lemley, A. T.; Bloom, S. E. Toxicol. Sci.
2003, 74, 66.
I
R
I2
R
O
N
N
OH
1
2
3. (a) Petrowitsch, T.; Eilbracht, P. Synlett 1997, 287; (b) Derdau, V.; Laschat, S.;
Jones, P. G. Heterocycles 1998, 48, 1445; (c) Kerr, W. J.; Kirk, G. G.; Middlemiss,
D. Synlett 1995, 1085; (d) Hamuro, Y.; Geib, S. J.; Hamilton, A. D. J. Am. Chem.
Soc. 1996, 118, 7529; (e) O’Neil, I. A.; Turner, C. D.; Kalindjian, S. B. Synlett 1997,
777; (f) Derdau, V.; Laschat, S.; Hupe, E.; König, W. A.; Dix, I.; Jones, P. G. Eur. J.
Inorg. Chem. 1999, 1001.
I+
- H+
I
I
R
R
4. (a) Sakamoto, T.; Kondo, Y.; Miura, N.; Hayashi, K.; Yamanaka, H. Heterocycles
1986, 24, 2311; (b) Sakamoto, T.; Numata, A.; Kondo, Y. Chem. Pharm. Bull.
2000, 48, 669.
N
N
OH
OH
5. The following paper was published during the preparation of the present
manuscript: Yeom, H.-S.; Kim, S.; Shin, S. Synlett 2008, 924.
Scheme 1. A plausible mechanism for the formation of 2.
6. Asao, N.; Yudha, S.; Nogami, T.; Yamamoto, Y. Angew. Chem. Int. Ed. 2005, 44,
5526.
7. Asao, N.; Iso, K.; Yudha, S. Org. Lett. 2006, 8, 4149.
8. Fischer, D.; Tomeba, H.; Pahadi, N. K.; Patil, N. T.; Yamamoto, Y. Angew. Chem.
Int. Ed. 2007, 46, 4764.
we thought that application of this
a
-cyanation to our iodoisoquin-
oline N-oxides would lead to formation of 1,3,4-trisubstituted iso-
quinolines. The reactions of iodoisoquinoline N-oxides 2a, 2f, and
2g were carried out in THF at 75 °C for 30 min in the presence of
TMSCN and DBU to give the desired cyanoisoquinolines 3a, 3f,
and 3g in high yields (Eq. 6).11
9. The procedure for the synthesis of isoquinoline N-oxide 2ais as follows. To a
5 mL screw capped vial equipped with a magnetic stirring bar were added 2-
phenylalkynylbenzaldoxime (66.4 mg, 0.3 mmol), iodine (380.7 mg, 1.5 mmol)
and dry ethanol (3 mL) under an argon atmosphere. The reaction mixture was
stirred at room temperature for 15 min, and the progress of the reaction was
monitored by TLC (hexane/ethyl acetate; 2:1). After complete consumption of
the starting material, saturated aqueous Na2S2O3 was added, and stirring was
continued for 5–15 min. The mixture was extracted with CH2Cl2 (2 ꢀ 20 mL)
and dried over anhydrous magnesium sulfate. The solvent was removed under
reduced pressure, and the residue was purified by column chromatography
(silica gel, CH2Cl2/EtOH; 50/1–5/1) to afford product 2a in 94% yield (97.9 mg).
Mp: 230–231 °C; 1H NMR (500 MHz, CDCl3): d 7.41–7.37 (m, 2H), 7.58–7.48 (m,
3H), 7.70–7.61 (m, 3H), 8.08 (d, J = 8.0 Hz, 1H), 8.86 (s, 1H); 13C NMR (75 MHz,
CDCl3): 101.79, 125.21, 128.37, 128.64, 129.42, 129.58, 129.76, 130.33, 131.72,
TMSCN (1.2 equiv)
DBU (2.2 equiv)
N
ð5Þ
N
THF, reflux, 30 min
97%
O
CN
I
I
TMSCN (1.5 equiv)
DBU (3.3 equiv)
R
R
O
132.54, 136.78, 137.21, 151.04; IR (KBr) 1307, 1171, 1119, 773, 752 cmꢁ1
;
N
HRMS (EI) calcd for C15H10INO ([M+Na]+) 369.9705. Found. 369.9699.
THF, 75 oC, 30 min
N
10. Miyashita, A.; Kawashima, T.; Iijima, C.; Higashino, T. Heterocycles 1992, 33,
211.
CN
, 84% (mp: 161-162 oC)
3f, 88% (mp: 138-139 oC)
3g
2a
3a
, R = Ph
, R = Bn
11. The procedure for the synthesis of cyanoisoquinoline 3a from 2a is as follows.
To a 5 mL screw capped vial equipped with a magnetic stirring bar were added
compound 2a (104.1 mg, 0.3 mmol), TMSCN (0.06 mL, 0.45 mmol), DBU
(0.15 mL, 0.99 mmol) and THF (3 mL). The reaction mixture was stirred at
75 °C for 30 min, and the progress of the reaction was monitored by TLC
(hexane/ethyl acetate; 5:1). After complete consumption of the starting
material, the reaction mixture was cooled to room temperature, saturated
aqueous NH4Cl was added, and stirring was continued for 5–15 min. The
mixture was extracted with CH2Cl2 (2 ꢀ 20 mL) and dried over anhydrous
magnesium sulfate. The solvent was removed under reduced pressure, and the
residue was purified by column chromatography (silica gel, hexane/ethyl
acetate; 20/1–5/1) to afford product 3a in 84% yield (89.3 mg). Mp: 161–
162 °C; 1H NMR (500 MHz, CDCl3): d 7.55–7.46 (m, 3H), 7.64–7.59 (m, 2H),
7.86 (t, J = 8.0 Hz, 1H), 7.95 (t, J = 8.0 Hz, 1H), 8.35 (d, J = 8.0 Hz, 2H); 13C NMR
(75 MHz, CDCl3): 103.84, 115.13, 125.75, 127.90, 128.07, 128.90, 129.67,
130.28, 133.29, 133.45, 134.25, 139.10, 142.08, 157.83. IR (KBr) 2228, 1537,
1264, 916, 766, 744 cmꢁ1; HRMS (EI) calcd for C16H9IN2 ([M+Na]+) 378.9708.
Found. 378.9703.
2f
2g, R = Cyclohexenyl
, 92% (mp: 108-109 oC)
ð6Þ
In conclusion, we have developed a new and efficient procedure
for the synthesis of 3,4-disubstituted iodoisoquinoline N-oxides
from 2-alkynylbenzaldoximes. We also demonstrated that 1,3,4-
trisubstituted isoquinolines may be derived from these iodo-
isoquinoline N-oxides. Further studies to extend the scope of this
procedure are in progress in our laboratory.
References and notes
1. Bentley, K. W. In The Isoquinoline Alkaloids; Harwood Academic: Amsterdam,
1998; Vol. 1.